Shengchen Lin
Impact in
- Sensory Systems top 5%
- Ion Channels and Receptors
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cellular Mechanics and Interactions 3
-
- Ion Channels and Receptors 2
- Co-authors
- Shengyu Yang (8 shared papers)Pankaj K. Singh (5 shared papers)Jihui Hao (5 shared papers)Matthew D. Taylor (3 shared papers)Lihua Jin (5 shared papers)Chongbiao Huang (4 shared papers)Jianwei Sun (5 shared papers)Weili Zheng (4 shared papers)
- Journals
- Journal of Biological Chemistry (2 papers)Molecular Pharmacology (1 paper)Arthritis Research & Therapy (1 paper)Cancer Research (1 paper)FEBS Journal (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Shengchen Lin
17 papers receiving 720 citations
Peers
Comparison fields: 5 of 81
- Sensory Systems 87
- Cancer Research 116
- Cell Biology 104
- Oncology 140
- Toxicology 18
Countries citing papers authored by Shengchen Lin
This map shows the geographic impact of Shengchen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengchen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengchen Lin more than expected).
Fields of papers citing papers by Shengchen Lin
This network shows the impact of papers produced by Shengchen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengchen Lin. The network helps show where Shengchen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengchen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 130 | |
| 2 | 2014 | 119 | |
| 3 | 2022 | 84 | |
| 4 | 2021 | 72 | |
| 5 | 2019 | 60 | |
| 6 | 2020 | 46 | |
| 7 | 2016 | 37 | |
| 8 | 2019 | 32 | |
| 9 | 2017 | 32 | |
| 10 | 2011 | 25 | |
| 11 | 2017 | 24 | |
| 12 | 2012 | 21 | |
| 13 | 2011 | 18 | |
| 14 | 2018 | 14 | |
| 15 | 2023 | 10 | |
| 16 | 2015 | 5 | |
| 17 | 2023 | 3 |
About Shengchen Lin
Shengchen Lin is a scholar working on Cell Biology, Sensory Systems, Molecular Biology, Pharmacology and Oncology, having authored 17 papers that have together received 732 indexed citations. Recurring topics across this work include Cellular Mechanics and Interactions (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Retinoids in leukemia and cellular processes (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Inflammatory mediators and NSAID effects (2 papers), Ion Channels and Receptors (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Sensory Systems (87 citations), Cancer Research (116 citations), Cell Biology (104 citations), Oncology (140 citations) and Toxicology (18 citations). Shengchen Lin has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Shengyu Yang, Pankaj K. Singh, Jihui Hao, Matthew D. Taylor, Lihua Jin, Chongbiao Huang, Jianwei Sun, Weili Zheng, Hui Yong Rong and Yong Li. Their work appears in journals such as Journal of Biological Chemistry, Molecular Pharmacology, Arthritis Research & Therapy, Cancer Research and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.